Want to join the conversation?
$CBM, a life sciences company, said it appointed Claes Glassell to its BoD for a term expiring on the date of its 2016 annual meeting. Glassell will also serve on the Board's Audit and Regulatory Affairs Committees. This latest appointment, increases the size of the Board to ten members.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.